JNCCN 360 - Non-Melanoma Skin Cancers

Editor:

Karl D. Lewis, MD

Advertisement

Advertisement

Francis P. Worden, MD, on Vismodegib: Organ Preservation for Orbital/Periocular Basal Cell Carcinoma

Nikolaos Andreatos, MD, on Adverse Events Following Radiotherapy and Immunotherapy in Patients With Melanoma and Merkel Cell Carcinoma

Danny Rischin, MD, on Cutaneous Squamous Cell Carcinoma: Follow-up Data on Cemiplimab

Recent

Epidermal Radioisotope Therapy Using Rhenium-188 for Non-Melanoma Skin Cancer

Do Topical Calcineurin Inhibitors Increase the Risk for Skin Cancer?

Finnish Study Shows Benefit of Full-Body Skin Exams in Older Adults

Effects of Immunosuppression in Merkel Cell Carcinoma

Published

Medical Literature

Dermatoscopic Morphology: Predicting Nodular Non-Melanoma Versus Melanoma

Radiotherapy for Merkel Cell Carcinoma: Multidisciplinary Team Approach

Case of Basal Cell Carcinoma: Complications From Self-Treatment With Bloodroot Plant

Skin Cancer in Recipients of Liver and Kidney Transplants: Calcineurin Versus mTOR Inhibitors

Ongoing

The Role Of PD-1 Inhibitors in The Evolving Landscape of Advanced Cutaneous Squamous Cell Carcinoma Treatment

A Multidisciplinary Approach to Individualized Patient Care: Non-Melanoma Skin Cancer

No Elevated Cancer Risk for RA Patients With Tocilizumab

Could AI Trained to ID Skin Cancer Attain Accuracy of Dermatologists?

Available

Clinical Trials

Memorial Sloan Kettering Cancer Center

Seidman Cancer Center

Fox Chase Cancer Center

The Sidney Kimmel Comprehensive Cancer Center

NCCN Resources

Copyright © 2020 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.